Guangdong VTR Bio-Tech Co., Ltd. (300381.SZ)
CNY 8.04
(1.9%)
CNY 8.04
(1.9%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 123.9 Million CNY | -63.67% |
| 2022 | 269.15 Million CNY | -2.83% |
| 2021 | 128.45 Million CNY | -39.76% |
| 2020 | 440.78 Million CNY | 7.53% |
| 2019 | 373.87 Million CNY | 4.33% |
| 2018 | 345.97 Million CNY | 23.74% |
| 2017 | 283.6 Million CNY | 5.43% |
| 2016 | 290.82 Million CNY | 115.0% |
| 2015 | 141.86 Million CNY | 81.9% |
| 2014 | 76.96 Million CNY | -6.09% |
| 2013 | 84.04 Million CNY | 15.01% |
| 2012 | 73.77 Million CNY | 21.68% |
| 2011 | 61.23 Million CNY | 27.12% |
| 2010 | 45.54 Million CNY | 33.32% |
| 2009 | 36.52 Million CNY | 24.07% |
| 2008 | 29.12 Million CNY | 103.25% |
| 2007 | 14.32 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 16.3 Million CNY | 352.62% |
| 2024 Q3 | 7.06 Million CNY | -70.9% |
| 2024 Q2 | 26.74 Million CNY | -50.88% |
| 2023 Q4 | -40.61 Million CNY | -651.84% |
| 2023 FY | - CNY | -63.67% |
| 2023 Q1 | -10.29 Million CNY | 1.34% |
| 2023 Q2 | 29.42 Million CNY | 385.72% |
| 2023 Q3 | 7.36 Million CNY | -74.99% |
| 2022 Q3 | 21.96 Million CNY | -84.0% |
| 2022 Q1 | -17.45 Million CNY | 57.42% |
| 2022 Q2 | 137.31 Million CNY | 886.49% |
| 2022 FY | - CNY | -2.83% |
| 2022 Q4 | -10.43 Million CNY | -147.53% |
| 2021 Q1 | 46.52 Million CNY | -47.07% |
| 2021 Q2 | 54.42 Million CNY | 16.98% |
| 2021 Q3 | 49.69 Million CNY | -8.68% |
| 2021 Q4 | -40.99 Million CNY | -182.49% |
| 2021 FY | - CNY | -39.76% |
| 2020 Q1 | 50.04 Million CNY | -41.23% |
| 2020 Q3 | 90.04 Million CNY | 16.15% |
| 2020 Q4 | 87.9 Million CNY | -2.39% |
| 2020 FY | - CNY | 7.53% |
| 2020 Q2 | 77.52 Million CNY | 54.92% |
| 2019 Q3 | 81.64 Million CNY | -9.27% |
| 2019 FY | - CNY | 4.33% |
| 2019 Q1 | 18.25 Million CNY | -83.78% |
| 2019 Q2 | 89.98 Million CNY | 392.94% |
| 2019 Q4 | 85.14 Million CNY | 4.3% |
| 2018 FY | - CNY | 23.74% |
| 2018 Q4 | 112.51 Million CNY | 48.28% |
| 2018 Q3 | 75.88 Million CNY | 121.68% |
| 2018 Q2 | 34.23 Million CNY | -42.17% |
| 2018 Q1 | 59.18 Million CNY | -49.13% |
| 2017 Q3 | 40.46 Million CNY | 58.15% |
| 2017 FY | - CNY | 5.43% |
| 2017 Q4 | 116.34 Million CNY | 187.55% |
| 2017 Q1 | 34.4 Million CNY | -64.23% |
| 2017 Q2 | 25.58 Million CNY | -25.62% |
| 2016 Q4 | 96.18 Million CNY | 57.75% |
| 2016 Q3 | 60.97 Million CNY | 14.51% |
| 2016 Q2 | 53.24 Million CNY | 198.81% |
| 2016 FY | - CNY | 115.0% |
| 2016 Q1 | 17.81 Million CNY | -59.6% |
| 2015 FY | - CNY | 81.9% |
| 2015 Q4 | 44.1 Million CNY | 31.14% |
| 2015 Q3 | 33.63 Million CNY | 20.65% |
| 2015 Q2 | 27.87 Million CNY | 247.21% |
| 2015 Q1 | 8.02 Million CNY | -39.21% |
| 2014 FY | - CNY | -6.09% |
| 2014 Q4 | 13.2 Million CNY | -48.82% |
| 2014 Q3 | 25.8 Million CNY | 76.65% |
| 2014 Q2 | 14.6 Million CNY | 16.94% |
| 2014 Q1 | 12.48 Million CNY | -21.61% |
| 2013 Q1 | 15.04 Million CNY | 108.13% |
| 2013 FY | - CNY | 15.01% |
| 2013 Q3 | 25.05 Million CNY | 30.05% |
| 2013 Q2 | 19.26 Million CNY | 28.09% |
| 2013 Q4 | 15.93 Million CNY | -36.41% |
| 2012 Q3 | 99.49 Million CNY | 0.0% |
| 2012 FY | - CNY | 21.68% |
| 2012 Q4 | -185 Million CNY | -285.95% |
| 2011 FY | - CNY | 27.12% |
| 2010 Q4 | 8.78 Million CNY | 0.0% |
| 2010 FY | - CNY | 33.32% |
| 2009 FY | - CNY | 24.07% |
| 2008 FY | - CNY | 103.25% |
| 2007 FY | - CNY | 0.0% |